These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26205955)

  • 1. Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.
    Hektoen HH; Flatmark K; Andersson Y; Dueland S; Redalen KR; Ree AH
    BMC Cancer; 2015 Jul; 15():543. PubMed ID: 26205955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
    Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
    Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
    Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
    Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
    Woelber L; Mueller V; Eulenburg C; Schwarz J; Carney W; Jaenicke F; Milde-Langosch K; Mahner S
    Gynecol Oncol; 2010 May; 117(2):183-8. PubMed ID: 20051287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy.
    Mayer A; Vaupel P; Oberholzer K; Ebert M; Dimitrow M; Kreft A; Mueller-Klieser W; Schmidberger H
    Adv Exp Med Biol; 2016; 876():195-200. PubMed ID: 26782212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
    Müller V; Riethdorf S; Rack B; Janni W; Fasching PA; Solomayer E; Aktas B; Kasimir-Bauer S; Zeitz J; Pantel K; Fehm T;
    Breast Cancer Res; 2011 Jul; 13(4):R71. PubMed ID: 21745383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer.
    Brown-Glaberman U; Marron M; Chalasani P; Livingston R; Iannone M; Specht J; Stopeck AT
    Dis Markers; 2016; 2016():9810383. PubMed ID: 26941473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening.
    Kalanxhi E; Hektoen HH; Meltzer S; Dueland S; Flatmark K; Ree AH
    BMC Cancer; 2016 Jul; 16():536. PubMed ID: 27461255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
    Alves WEFM; Bonatelli M; Dufloth R; Kerr LM; Carrara GFA; da Costa RFA; Scapulatempo-Neto C; Tiezzi D; da Costa Vieira RA; Pinheiro C
    BMC Cancer; 2019 Dec; 19(1):1173. PubMed ID: 31795962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.
    Seierstad T; Hole KH; Grøholt KK; Dueland S; Ree AH; Flatmark K; Redalen KR
    Br J Radiol; 2015 Jul; 88(1051):20150097. PubMed ID: 25899892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.
    Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P
    Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: opportunities for signaling-adapted therapies.
    Ree AH; Flatmark K; Saelen MG; Folkvord S; Dueland S; Geisler J; Redalen KR
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):114-24. PubMed ID: 25624177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
    J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas.
    Guedj N; Bretagnol F; Rautou PE; Deschamps L; Cazals-Hatem D; Bedossa P; Panis Y; Couvelard A
    Hum Pathol; 2011 Nov; 42(11):1702-9. PubMed ID: 21531003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
    Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
    Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.
    Woelber L; Kress K; Kersten JF; Choschzick M; Kilic E; Herwig U; Lindner C; Schwarz J; Jaenicke F; Mahner S; Milde-Langosch K; Mueller V; Ihnen M
    BMC Cancer; 2011 Jan; 11():12. PubMed ID: 21223596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer.
    Rasheed S; Harris AL; Tekkis PP; Turley H; Silver A; McDonald PJ; Talbot IC; Glynne-Jones R; Northover JM; Guenther T
    Pathol Res Pract; 2009; 205(1):1-9. PubMed ID: 19008051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.